TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

• Main Authors: NORA TARCIC, DINA KOFLER, DAN BAR-ZOHAR
• Format: Patent
• Language: English; Spanish
• Published: 23.02.2012
• Subjects: AGRICULTURE; ANIMAL HUSBANDRY; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; FISHING; FORESTRY; HUMAN NECESSITIES; HUNTING; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF; TRAPPING

The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing- remitting multiple sclerosis human patient. La invención objeto proporciona métodos para reducir la velocidad de recaída y/o reducir la acumulación de discapacidad física en un paciente humano con esclerosis múltiple recurrente-remitente, el método comprende administrar oralmente al paciente una dosis diaria de 0.6 mg de laquinimod. La invención objeto también proporciona formas de dosificación de unidad oral farmacéuticas de 0.6 mg de laquinimod para usar en reducir la velocidad de recaída y/o para usar en reducir la acumulación de discapacidad física en un paciente humano con esclerosis múltiple recurrente-remitente.